Current studies focus mainly on two receptor systems -
the mast cell surface receptor, FcεRI, and the receptor for epidermal growth factor that operate in immunological and cell proliferation responses.
Not exact matches
New findings published in the journal Nature Chemical Biology by UNC School of Medicine scientists show that MRGRPX2, a
receptor protein on the
surface of
mast cells, can trigger the immune system response that leads to itching associated with some opioids.
Right: exon skipping treatment eliminates trafficking of the IgE
receptor to the
surface of
mast cells, rendering the
cells unresponsive to allergen - mediated
mast cell activation.
Left:
mast cells are activated by allergens reacting with IgE bound to IgE
receptors on the
mast cell surface to trigger the release of histamine and other inflammatory mediators that orchestrate an allergic response including recruitment of inflammatory
cells.
«By eliminating the expression of the IgE
receptor on the
surface of
mast cells, we have identified an innovative and targeted approach with the potential to treat allergic inflammation in millions of patients worldwide.
The researchers utilized a technique known as exon skipping, a form of RNA splicing, to eliminate the portion of one of the IgE
receptor gene's mRNA that is essential to making a protein which places the IgE
receptor on the
mast cell surface.